MYC and lymphoma: However, a comprehensive and systematic analysis of GATA-3 target genes in malignant T cells demonstrated that GATA-3 targets (e.g. including c-myc) are oncogenic, and further demonstrated via loss-of-function and gain-of-function studies that GATA-3 is a bona fide proto-oncogene in these lymphomas (39).